Mercks Belzutifan Approved for Treating VHL-Related Cancers
| 86562MBG4 | 94.39 4.62 4.67% |
About 62% of SUMITOMO's investor base is looking to short. The analysis of the overall prospects from investing in SUMITOMO MITSUI FINL suggests that many traders are, at the present time, alarmed. The current market sentiment, together with SUMITOMO's historical and current headlines, can help investors time the market. In addition, many technical investors use SUMITOMO MITSUI FINL bond news signals to limit their universe of possible portfolio assets.
SUMITOMO |
The National Medical Products Administration has approved Mercks Belzutifan tablets for the treatment of von Hippel-Lindau disease-associated renal
Read at gurufocus.com
 |
SUMITOMO Fundamental Analysis
We analyze SUMITOMO's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SUMITOMO using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SUMITOMO based on its fundamental data. In general, a quantitative approach, as applied to this corporate bond, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
SUMITOMO MITSUI cannot be rated in Probability Of Bankruptcy category at this point.Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
SUMITOMO MITSUI FINL Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with SUMITOMO bond to make a market-neutral strategy. Peer analysis of SUMITOMO could also be used in its relative valuation, which is a method of valuing SUMITOMO by comparing valuation metrics with similar companies.
Peers
SUMITOMO Related Equities
| NCMI | National CineMedia | 1.31 | ||||
| PLTK | Playtika Holding | 1.08 | ||||
| EME | EMCOR | 0.43 | ||||
| XPOF | Xponential Fitness | 0.20 | ||||
| MYRG | MYR | 0.08 | ||||
| J | Jacobs Solutions | 0.01 | ||||
| ECG | Everus Construction | 1.55 | ||||
| MSN | Emerson Radio | 4.65 |
Other Information on Investing in SUMITOMO Bond
SUMITOMO financial ratios help investors to determine whether SUMITOMO Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SUMITOMO with respect to the benefits of owning SUMITOMO security.